Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-055856

Chief Scientific Officer sold 2,146 shares at $67.23 ($144,276)

  • Chief Scientific Officer acquired 2,146 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Biller Scott · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2017-10-02 Exercise or conversion : show line 1 in the form +1,191 $9.05 $10,779 7,455 D
2017-10-02 Sale : show line 2 in the form −1,191 $67.23 $80,071 6,264 D
2017-10-02 Exercise or conversion : show line 3 in the form +955 $31.64 $30,216 7,219 D
2017-10-02 Sale : show line 4 in the form −955 $67.23 $64,205 6,264 D
Open-market sales · 2,146 sh · avg $67.23 · $144,276

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-10-02 Exercise or conversion : show line 5 in the form Stock option (right to buy) −1,191 34,090 D
2017-10-02 Exercise or conversion : show line 6 in the form Stock option (right to buy) −955 34,331 D
Loading xslF345X03/doc4.xml…